A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
Maslak, P G, Dao, T, Gomez, M, Chanel, S, Packin, J, Korontsvit, T, Zakhaleva, V, Pinilla-Ibarz, J, Berman, E, Scheinberg, D A
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article